Exane Derivatives’s iShares China Large-Cap ETF FXI Stock Holding History
Bought
Maintained
Sold
Other funds holding FXI
CS
Exane Derivatives's FXI Position: Q2 2022 in Review
Exane Derivatives reduced its iShares China Large-Cap ETF (FXI) stake by 25% in Q2 2022, selling an estimated $94 and leaving 9 shares worth $305. The position accounts for ﹤0.01% of the portfolio, ranked #638.
Exane Derivatives first reported a position in FXI in Q4 2014 and has held it in 31 quarters since. The position peaked at $41.4M in Q4 2017. 283 funds tracked by Wall St. Rank hold FXI as of Q2 2022.
- Exane Derivatives held 9 shares of iShares China Large-Cap ETF worth $305 as of Q2 2022.
- Exane Derivatives sold 3 iShares China Large-Cap ETF shares in Q2 2022, an estimated $94.
- iShares China Large-Cap ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #638 holding.
- Exane Derivatives first reported a position in iShares China Large-Cap ETF in Q4 2014 and has held it in 31 quarters since.
- Exane Derivatives's iShares China Large-Cap ETF position peaked at $41.4M in Q4 2017.
- 283 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.